Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results.
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours - British Journal of Cancer
Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells - Breast Cancer Research
The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy. - Gynecological Oncology
Epistaxis during treatment with paclitaxel.
HER2 and Response to Paclitaxel in Node-Positive Breast Cancer - New England Journal of Medicine